Early expression of cyclo‐oxygenase‐2 during sporadic colorectal carcinogenesis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Pathology

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9896(199902)187:3<295::AID-PATH254>3.0.CO;2-YPMID 10398082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• High frequency of K-ras mutations in human colorectal hyperplastic polyps.

  1997cited by this paper
• Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis

  1997cited by this paper
• ASEPTIC LOOSENING OF TOTAL HIP REPLACEMENT: MACROPHAGE EXPRESSION OF INDUCIBLE NITRIC OXIDE SYNTHASE AND CYCLO-OXYGENASE-2, TOGETHER WITH PEROXYNITRITE FORMATION, AS A POSSIBLE MECHANISM FOR EARLY PROSTHESIS FAILURE

  1997cited by this paper
• K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.

  1997cited by this paper
• Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure.

  1997cited by this paper
• Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.

  1997cited by this paper
• POSITIVE CORRELATION BETWEEN APOPTOTIC AND PROLIFERATIVE INDICES IN GASTROINTESTINAL LYMPHOMAS OF MUCOSA‐ASSOCIATED LYMPHOID TISSUE (MALT)

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Elevated cyclooxygenase-2 levels in Min mouse adenomas.

  1996cited by this paper
• Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

  1995cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?

  1995cited by this paper
• The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition?

  1994cited by this paper
• Generation of mutagens during arachidonic acid metabolism

  1994cited by this paper
• Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals

  1994cited by this paper
• Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.

  1994cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.

  1994cited by this paper
• Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

  1993cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Cyclooxygenase Gene Expression in Inflammation and Angiogenesis a

  1993cited by this paper
• Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group.

  1993cited by this paper
• Aspirin use, cancer, and polyps of the large bowel

  1993cited by this paper
• Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

  1993cited by this paper
• Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.

  1993cited by this paper
• The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration

  1993cited by this paper
• Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.

  1993cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper
• Altered eicosanoid levels in human colon cancer.

  1993cited by this paper
• Prostanoid biosynthesis and mechanisms of action.

  1992cited by this paper
• E2 prostaglandins modulate cell proliferation in the small intestinal epithelium of the rat.

  1992cited by this paper
• Aspirin and the potential role of prostaglandins in colon cancer.

  1992cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• A new view of prostaglandin E regulation of the immune response.

  1991cited by this paper
• Sulindac causes regression of rectal polyps in familial adenomatous polyposis.

  1991cited by this paper
• Sulindac inhibits the rate of growth and appearance of colon tumors in the rat.

  1991cited by this paper
• Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.

  1991cited by this paper
• A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

  1991cited by this paper
• Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.

  1990cited by this paper
• Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer

  1990cited by this paper
• Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

  1988cited by this paper
• Role of arachidonic acid metabolism in the mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor.

  1988cited by this paper
• Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues.

  1987cited by this paper
• The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis

  1987cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper
• 16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin.

  1985cited by this paper
• Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium.

  1983cited by this paper
• Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1

  year unknowncited by this paper

• Network of Extracellular Traps in the Pathogenesis of Sterile Chronic Inflammatory Diseases: Role of Oxidative Stress and Potential Clinical Applications

  2023cites this paper
• Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines

  2023cites this paper
• Development of Pluoronic nanoparticles of fluorocoxib A for endoscopic fluorescence imaging of colonic adenomas

  2023cites this paper
• Role of membrane lipids in colon differentiation unravelled by mass spectrometry imaging: arachidonic acid beyond inflammation

  2020cites this paper
• Infectious Organisms Associated With Colorectal Cancer

  2019cites this paper
• Immunohistoc hemical localization of Inducible Nitric Oxide Synthase in Pleomorphic Adenoma of Salivary Gland: Correlation with Cyclooxygenase-2 and Tumor Proliferative Activity

  2018cites this paper
• Green Tea Polyphenols Inhibit Colorectal Tumorigenesis in Azoxymethane-Treated F344 Rats

  2017cites this paper
• Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo.

  2016cites this paper
• Lipid fingerprint image accurately conveys human colon cell pathophysiologic state: A solid candidate as biomarker.

  2016cites this paper
• Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.

  2015cites this paper
• Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.

  2014cites this paper
• Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature

  2013cites this paper
• Screening and Identification of Salicin Compound from Desmodium gangeticum and its In vivo Anticancer Activity and Docking Studies with Cyclooxygenase (COX) Proteins from Mus musculus

  2013cites this paper
• Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.

  2013cites this paper
• CYP2W1 in colorectal cancer : aspects of risk, prognosis and future treatment options

  2013cites this paper
• Role of prostaglandins in colorectal tumorigenesis: Localization and expression of COX-1, COX-2, microsomal Prostaglandin E Synthase-1 and the EP2 receptor

  2013cites this paper
• Inflammation in sporadic colorectal cancer.

  2012cites this paper
• Estudio de la expresión de ciclooxigenasa-2 como factor pronóstico en el cáncer colorrectal

  2012cites this paper
• Cyclo-Oxygenase-2 and its Inhibition in Cancer

  2012cites this paper
• Comparison of phenolic content, antioxidant capacity and anti-inflamatory activity of commercial herbal infusions

  2012cites this paper
• MOLECULAR PROFILE OF COLORECTAL CANCER IN INDONESIA: IS THERE ANOTHER PATHWAY? (REVIEW ARTICLE)

  2012cites this paper
• Molecular profile of colorectal cancer in Indonesia: is there another pathway?

  2012cites this paper
• Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial

  2011cites this paper
• Expression of Cyclooxygenase-1, -2, Peroxisome Proliferator-activated Receptor gamma in Human Colorectal Carcinoma.

  2010cites this paper
• Expression of cyclooxygenase-2 in colonic polyps.

  2010cites this paper
• Cytoplasmic phospholipase A2 metabolites play a critical role in pulmonary tumor metastasis in mice.

  2010cites this paper
• Localization of cyclo-oxygenase-2 in human recurrent colorectal cancer.

  2010cites this paper
• Role of Cyclooxygenase-2 in Pathogenesis and Prevention of Colorectal Cancer

  2010cites this paper
• Prostanoids and colorectal cancer

  2010cites this paper
• Localization of cyclooxygenase-2 in human recurrent colorectal cancer

  2010cites this paper
• Cyclooxygenase Isoforms in Tumorigenesis

  2010cites this paper
• COX‐2 expression is unexpectedly high in viable colorectal mucosal cells: is there life for chemoprophylaxis after VICTOR?

  2009cites this paper
• Urinary markers in colorectal cancer.

  2009cites this paper
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

  2008cites this paper
• Cyclooxygenase activity and tumor progression

  2008cites this paper
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

  2008cites this paper
• PREVALENCE OF COX2 MARKER IN BENIGN AND MALIGNANT THYROID NEOPLASMS WITH IMMUNOHISTOCHEMISTRY METHOD

  2008cites this paper
• Cyclooxygenase activity and tumor progression

  2008cites this paper
• COX‐2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics

  2008cites this paper
• Preventive effects of glycyrrhizin on estrogen-related endometrial carcinogenesis in mice.

  2007cites this paper
• EP1–4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease‐specific mortality

  2007cites this paper
• The essential role of bone morphogenetic protein (BMP) signaling in organogenesis

  2007cites this paper
• Getting familiar with familial colon cancer

  2007cites this paper
• Estudo imunohistoquímico das expressões: hMLH1, hMSH2 e Cox-2 em pólipos do cólon

  2007cites this paper
• A reduced COX-2 expression and a reduced number of pericryptal myofibroblasts are associated with depressed adenoma of the colon.

  2007cites this paper
• Overexpression of cyclooxygenase-2 correlates with cytoplasmic HuR expression in salivary mucoepidermoid carcinoma but not in pleomorphic adenoma.

  2007cites this paper
• hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.

  2007cites this paper
• Cyclooxygenase-2 Gene Expression

  2006cites this paper
• Cyclooxygenase-2 Expression in Hepatocellular Carcinoma, Cirrhosis and Chronic Hepatitis in the United States

  2006cites this paper
• University of Groningen Apoptosis and colorectal cancer . Studies on pathogenesis and potential therapeutic

  2006influential citation
• Pioglitazone, a synthetic ligand for PPARγ, induces apoptosis in RB-deficient human colorectal cancer cells

  2006cites this paper
• Preferential Expression of Cyclooxygenase-2 in Colonic-Phenotype of Gastric Intestinal Metaplasia: Association With Helicobacter Pylori and Gastric Carcinoma

  2006cites this paper
• Cyclo-Oxygenase-2 Inhibitors in Colorectal Cancer Prevention

  2006cites this paper
• Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.

  2006cites this paper
• Altered Expression of β-catenin, E-cadherin, Cycloxygenase-2, and p53 Protein by Ovine Intestinal Adenocarcinoma Cells

  2006cites this paper
• Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production.

  2006cites this paper
• COX-2 overexpression in canine tumors: potential therapeutic targets in oncology.

  2005cites this paper
• Studies on pathogenesis and potential therapeutic targets

  2005cites this paper
• Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.

  2005cites this paper
• Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis.

  2005cites this paper
• [COX-2 inhibitors in cancer prevention].

  2005cites this paper
• Increased Cyclooxygenase-2 Expression in Duodenal Compared with Colonic Tissues in Familial Adenomatous Polyposis and Relationship to the −765G → C COX-2 Polymorphism

  2005cites this paper
• Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.

  2005cites this paper
• Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.

  2005cites this paper
• Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer: Rofecoxib in experimental colon cancer

  2005cites this paper
• Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

  2005cites this paper
• Cyclo-Oxygenase-2 Enzyme and Its Inhibition in Tumor Growth and Therapy

  2005cites this paper
• Inhibidores de la ciclooxigenasa-2 en la prevención del cáncer

  2005cites this paper
• Estudio de la expresión de ciclooxigenasa-2 como factor pronóstico en el cáncer colorrectal esporádico

  2005cites this paper
• Mechanisms of colon cancer prevention with and beyond COX-2 inhibition.

  2005cites this paper
• [Cyclooxygenase-2 expression as a prognostic factor in sporadic colorectal cancer].

  2005cites this paper
• Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.

  2005cites this paper
• Mechanisms and markers of carcinogenesis and neoplastic progression

  2005cites this paper
• 9 - Immunohistochemical Detection of Cyclooxygenase-2 in Pancreatic Ductal Adenocarcinomas and Neuroendocrine Tumors

  2005cites this paper
• Clinicopathologic and prognostic significance of cyclooxygenase-2 expression in endometrial carcinoma.

  2005cites this paper
• Cyclooxygenase-2 in sporadic colorectal polyps: immunohistochemical study and its importance in the early stages of colorectal tumorigenesis.

  2005cites this paper
• Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production.

  2004cites this paper
• Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

  2004cites this paper
• Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas

  2004cites this paper
• Cyclooxygenase-2 and its role in colorectal cancer development

  2004cites this paper
• Cyclooxygenase-2 and p53 expressions in endometrial cancer.

  2004cites this paper
• Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid.

  2004cites this paper
• RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer

  2004cites this paper
• The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas

  2004cites this paper
• Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent.

  2004cites this paper
• Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.

  2004cites this paper
• Cyclooxygenase-2 Overexpression Is Related to Polypoid Growth and K-ras Gene Mutation in T1 Colorectal Carcinomas

  2004cites this paper
• Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy.

  2004cites this paper
• Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.

  2004cites this paper
• COX-2 inhibition as a tool to treat and prevent colorectal cancer.

  2004cites this paper
• Expression of cyclooxygenase‐2 in cholangiocarcinoma: Correlation with clinicopathological features and prognosis

  2004cites this paper
• Expression of COX-2 proteins in gastric mucosal lesions.

  2004cites this paper
• Relationship among COX-2 protein expression, PGs levels and biologic behavior in ovarian carcinoma tissues

  2004cites this paper
• Prognostic Significance of Cyclooxygenase-2(COX-2) Expression in Primary, Resected Non-Small Cell Lung Cancer.

  2004cites this paper
• Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature.

  2003cites this paper
• The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.

  2003cites this paper
• Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents.

  2003cites this paper
• Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors)

  2003cites this paper
• Cyclo‐oxygenase 2 inhibition in colorectal cancer therapy

  2003cites this paper
• Association between Cyclooxygenase expression and colorectal adenoma characteristics.

  2003cites this paper